{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T22:08:27Z","timestamp":1777586907821,"version":"3.51.4"},"reference-count":45,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2011,8,1]],"date-time":"2011-08-01T00:00:00Z","timestamp":1312156800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,8,1]],"date-time":"2011-08-01T00:00:00Z","timestamp":1312156800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004737","name":"National Health Research Institutes","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004737","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001868","name":"National Science Council","doi-asserted-by":"publisher","award":["NHRI-EX99-9917NC"],"award-info":[{"award-number":["NHRI-EX99-9917NC"]}],"id":[{"id":"10.13039\/501100001868","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001868","name":"National Science Council","doi-asserted-by":"publisher","award":["97-3112-B-006-008"],"award-info":[{"award-number":["97-3112-B-006-008"]}],"id":[{"id":"10.13039\/501100001868","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001868","name":"National Science Council","doi-asserted-by":"publisher","award":["96-2320-B-006-018-MY3"],"award-info":[{"award-number":["96-2320-B-006-018-MY3"]}],"id":[{"id":"10.13039\/501100001868","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2011,8]]},"DOI":"10.1016\/j.bbrc.2011.07.099","type":"journal-article","created":{"date-parts":[[2011,8,2]],"date-time":"2011-08-02T04:52:30Z","timestamp":1312260750000},"page":"334-340","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["Increased galectin-3 facilitates leukemia cell survival from apoptotic stimuli"],"prefix":"10.1016","volume":"412","author":[{"given":"Yi-Lin","family":"Cheng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei-Ching","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chia-Ling","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheng-Chieh","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chi-Yun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei-Hsin","family":"Chiu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuh-Ling","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yee-Shin","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chuan-Fa","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiou-Feng","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2011.07.099_b0005","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1038\/nrc1527","article-title":"Galectins as modulators of tumour progression","volume":"5","author":"Liu","year":"2005","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bbrc.2011.07.099_b0010","doi-asserted-by":"crossref","first-page":"7527","DOI":"10.1038\/sj.onc.1207997","article-title":"Dual activities of galectin-3 in human prostate cancer: tumor suppression of nuclear galectin-3 vs tumor promotion of cytoplasmic galectin-3","volume":"23","author":"Califice","year":"2004","journal-title":"Oncogene"},{"key":"10.1016\/j.bbrc.2011.07.099_b0015","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s10495-005-0801-y","article-title":"On the role of galectin-3 in cancer apoptosis","volume":"10","author":"Nakahara","year":"2005","journal-title":"Apoptosis"},{"key":"10.1016\/j.bbrc.2011.07.099_b0020","first-page":"5272","article-title":"Galectin-3: a novel antiapoptotic molecule with a functional BH1 (NWGR) domain of Bcl-2 family","volume":"57","author":"Akahani","year":"1997","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbrc.2011.07.099_b0025","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.drup.2007.04.001","article-title":"The role of galectin-3 in cancer drug resistance","volume":"10","author":"Fukumori","year":"2007","journal-title":"Drug Resist. Updat."},{"key":"10.1016\/j.bbrc.2011.07.099_b0030","doi-asserted-by":"crossref","first-page":"6737","DOI":"10.1073\/pnas.93.13.6737","article-title":"Expression of galectin-3 modulates T-cell growth and apoptosis","volume":"93","author":"Yang","year":"1996","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.bbrc.2011.07.099_b0035","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1158\/0008-5472.CAN-08-4153","article-title":"Galectin-3 mediates nuclear beta-catenin accumulation and Wnt signaling in human colon cancer cells by regulation of glycogen synthase kinase-3beta activity","volume":"69","author":"Song","year":"2009","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbrc.2011.07.099_b0040","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.tibs.2003.12.004","article-title":"The glamour and gloom of glycogen synthase kinase-3","volume":"29","author":"Jope","year":"2004","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.bbrc.2011.07.099_b0045","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1186\/1476-4598-9-144","article-title":"Glycogen synthase kinase 3 beta: can it be a target for oral cancer","volume":"9","author":"Mishra","year":"2010","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.bbrc.2011.07.099_b0050","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.molcel.2006.02.009","article-title":"Glycogen synthase kinase-3 regulates mitochondrial outer membrane permeabilization and apoptosis by destabilization of MCL-1","volume":"21","author":"Maurer","year":"2006","journal-title":"Mol. Cell"},{"key":"10.1016\/j.bbrc.2011.07.099_b0055","doi-asserted-by":"crossref","first-page":"291","DOI":"10.3233\/JAD-2002-4404","article-title":"Interactions between GSK3beta and caspase signalling pathways during NGF deprivation induced cell death","volume":"4","author":"Bhat","year":"2002","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.bbrc.2011.07.099_b0060","doi-asserted-by":"crossref","first-page":"7583","DOI":"10.1074\/jbc.275.11.7583","article-title":"Glycogen synthase kinase-3beta facilitates staurosporine- and heat shock-induced apoptosis. Protection by lithium","volume":"275","author":"Bijur","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbrc.2011.07.099_b0065","doi-asserted-by":"crossref","first-page":"2567","DOI":"10.1523\/JNEUROSCI.20-07-02567.2000","article-title":"Role of glycogen synthase kinase-3beta in neuronal apoptosis induced by trophic withdrawal","volume":"20","author":"Hetman","year":"2000","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbrc.2011.07.099_b0070","doi-asserted-by":"crossref","first-page":"6027","DOI":"10.1128\/MCB.23.17.6027-6036.2003","article-title":"Lithium blocks the c-Jun stress response and protects neurons via its action on glycogen synthase kinase 3","volume":"23","author":"Hongisto","year":"2003","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.bbrc.2011.07.099_b0075","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/S0006-8993(01)03005-0","article-title":"Caspase-3 activation induced by inhibition of mitochondrial complex I is facilitated by glycogen synthase kinase-3beta and attenuated by lithium","volume":"919","author":"King","year":"2001","journal-title":"Brain Res."},{"key":"10.1016\/j.bbrc.2011.07.099_b0080","doi-asserted-by":"crossref","first-page":"41667","DOI":"10.1074\/jbc.M206405200","article-title":"Enhanced glycogen synthase kinase-3beta activity mediates hypoxia-induced apoptosis of vascular smooth muscle cells and is prevented by glucose transport and metabolism","volume":"277","author":"Loberg","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbrc.2011.07.099_b0085","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1182\/blood.V98.5.1374","article-title":"Growth factor withdrawal from primary human erythroid progenitors induces apoptosis through a pathway involving glycogen synthase kinase-3 and Bax","volume":"98","author":"Somervaille","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.bbrc.2011.07.099_b0090","doi-asserted-by":"crossref","first-page":"44701","DOI":"10.1074\/jbc.M206047200","article-title":"Central role of glycogen synthase kinase-3beta in endoplasmic reticulum stress-induced caspase-3 activation","volume":"277","author":"Song","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbrc.2011.07.099_b0095","doi-asserted-by":"crossref","first-page":"2935","DOI":"10.1242\/jcs.03473","article-title":"GSK-3beta acts downstream of PP2A and the PI 3-kinase-Akt pathway, and upstream of caspase-2 in ceramide-induced mitochondrial apoptosis","volume":"120","author":"Lin","year":"2007","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.bbrc.2011.07.099_b0100","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1182\/blood-2006-12-060947","article-title":"Inhibition of glycogen synthase kinase-3 activity leads to epigenetic silencing of nuclear factor kappaB target genes and induction of apoptosis in chronic lymphocytic leukemia B cells","volume":"110","author":"Ougolkov","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.bbrc.2011.07.099_b0105","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1038\/nature07284","article-title":"Glycogen synthase kinase 3 in MLL leukaemia maintenance and targeted therapy","volume":"455","author":"Wang","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.bbrc.2011.07.099_b0110","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.2174\/092986708784638834","article-title":"The role of glycogen synthase kinase-3beta in normal haematopoiesis, angiogenesis and leukaemia","volume":"15","author":"Holmes","year":"2008","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.bbrc.2011.07.099_b0115","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.ccr.2008.10.013","article-title":"Glycogen synthase kinase-3 and cancer: good cop, bad cop?","volume":"14","author":"Patel","year":"2008","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bbrc.2011.07.099_b0120","first-page":"1365","article-title":"Selective Akt inactivation and tumor necrosis actor-related apoptosis-inducing ligand sensitization of renal cancer cells by low concentrations of paclitaxel","volume":"63","author":"Asakuma","year":"2003","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbrc.2011.07.099_b0125","doi-asserted-by":"crossref","first-page":"3593","DOI":"10.1158\/0008-5472.CAN-03-2787","article-title":"Cisplatin-induced CD95 redistribution into membrane lipid rafts of HT29 human colon cancer cells","volume":"64","author":"Lacour","year":"2004","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbrc.2011.07.099_b0130","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.2174\/092986706777441986","article-title":"Ceramide in apoptotic signaling and anticancer therapy","volume":"13","author":"Lin","year":"2006","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.bbrc.2011.07.099_b0135","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1023\/A:1010624823158","article-title":"Role of ceramide during cisplatin-induced apoptosis in C6 glioma cells","volume":"52","author":"Noda","year":"2001","journal-title":"J. Neurooncol."},{"key":"10.1016\/j.bbrc.2011.07.099_b0140","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1080\/15216540701636287","article-title":"Understanding cisplatin resistance using cellular models","volume":"59","author":"Stordal","year":"2007","journal-title":"IUBMB Life"},{"key":"10.1016\/j.bbrc.2011.07.099_b0145","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/0378-1119(93)90764-T","article-title":"The pRSET family of T7 promoter expression vectors for Escherichia coli","volume":"124","author":"Schoepfer","year":"1993","journal-title":"Gene"},{"key":"10.1016\/j.bbrc.2011.07.099_b0150","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1023\/B:GLYC.0000014082.99675.2f","article-title":"Extracellular functions of galectin-3","volume":"19","author":"Ochieng","year":"2004","journal-title":"Glycoconj. J."},{"key":"10.1016\/j.bbrc.2011.07.099_b0155","doi-asserted-by":"crossref","first-page":"3114","DOI":"10.1158\/0008-5472.CAN-05-3750","article-title":"Galectin-3 regulates mitochondrial stability and antiapoptotic function in response to anticancer drug in prostate cancer","volume":"66","author":"Fukumori","year":"2006","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbrc.2011.07.099_b0160","doi-asserted-by":"crossref","first-page":"15819","DOI":"10.1074\/jbc.M200154200","article-title":"Galectin-3 translocates to the perinuclear membranes and inhibits cytochrome c release from the mitochondria. A role for synexin in galectin-3 translocation","volume":"277","author":"Yu","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbrc.2011.07.099_b0165","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/369321a0","article-title":"BH1 and BH2 domains of Bcl-2 are required for inhibition of apoptosis and heterodimerization with Bax","volume":"369","author":"Yin","year":"1994","journal-title":"Nature"},{"key":"10.1016\/j.bbrc.2011.07.099_b0170","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1111\/j.1432-1033.1996.0297t.x","article-title":"Membrane modifications in human erythroleukemia K562 cells during induction of programmed cell death by transforming growth factor beta 1 or cisplatin","volume":"241","author":"Maccarrone","year":"1996","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.bbrc.2011.07.099_b0175","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/sj.onc.1201533","article-title":"BCR-ABL accelerates C2-ceramide-induced apoptosis","volume":"16","author":"Maguer-Satta","year":"1998","journal-title":"Oncogene"},{"key":"10.1016\/j.bbrc.2011.07.099_b0180","first-page":"511","article-title":"Cisplatin-induced apoptosis in human promyelocytic leukemia cells","volume":"18","author":"Previati","year":"2006","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.bbrc.2011.07.099_b0185","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1182\/blood-2002-11-3429","article-title":"Survival of acute myeloid leukemia cells requires PI3 kinase activation","volume":"102","author":"Xu","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.bbrc.2011.07.099_b0190","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.bbagen.2005.12.020","article-title":"Galectin-3: an open-ended story","volume":"1760","author":"Dumic","year":"2006","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbrc.2011.07.099_b0195","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/S0002-9440(10)63177-X","article-title":"An anti-apoptotic role for galectin-3 in diffuse large B-cell lymphomas","volume":"164","author":"Hoyer","year":"2004","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.bbrc.2011.07.099_b0200","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0167-4889(03)00045-4","article-title":"Galectin-3 expression in macrophages is signaled by Ras\/MAP kinase pathway and up-regulated by modified lipoproteins","volume":"1641","author":"Kim","year":"2003","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbrc.2011.07.099_b0205","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0014-4827(03)00211-8","article-title":"Reconstitution of galectin-3 alters glutathione content and potentiates TRAIL-induced cytotoxicity by dephosphorylation of Akt","volume":"288","author":"Lee","year":"2003","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.bbrc.2011.07.099_b0210","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1038\/35055582","article-title":"Negative regulation of T-cell activation and autoimmunity by Mgat5 N-glycosylation","volume":"409","author":"Demetriou","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.bbrc.2011.07.099_b0215","first-page":"8302","article-title":"CD29 and CD7 mediate galectin-3-induced type II T-cell apoptosis","volume":"63","author":"Fukumori","year":"2003","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbrc.2011.07.099_b0220","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1159\/000016345","article-title":"Expression of galectin-3 in cells exposed to stress-roles of jun and NF-kappaB","volume":"10","author":"Dumic","year":"2000","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.bbrc.2011.07.099_b0225","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1359\/jbmr.070620","article-title":"HIF-1 alpha is a regulator of galectin-3 expression in the intervertebral disc","volume":"22","author":"Zeng","year":"2007","journal-title":"J. Bone Miner. Res."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X11013349?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X11013349?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T20:09:18Z","timestamp":1777406958000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X11013349"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,8]]},"references-count":45,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,8]]}},"alternative-id":["S0006291X11013349"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2011.07.099","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2011,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Increased galectin-3 facilitates leukemia cell survival from apoptotic stimuli","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2011.07.099","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}